MedPath
HSA Approval

LORACIN TABLET 10 mg

SIN12466P

LORACIN TABLET 10 mg

LORACIN TABLET 10 mg

November 22, 2003

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AX13

loratadine

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

DAE HAN NEW PHARM. CO. LTD.

Active Ingredients

LORATADINE

10 mg

Loratadine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LORACIN TABLET 10 mg - HSA Approval | MedPath